Precision medicine gains momentum: novel 3D models and stem cell-based approaches in head and neck cancer
Despite the current progress in the development of new concepts of precision medicine for head and neck squamous cell carcinoma (HNSCC), in particular targeted therapies and immune checkpoint inhibition (CPI), overall survival rates have not improved during the last decades. This is, on the one hand...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
8 July 2021
|
| In: |
Frontiers in cell and developmental biology
Year: 2021, Volume: 9, Pages: 1-27 |
| ISSN: | 2296-634X |
| DOI: | 10.3389/fcell.2021.666515 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fcell.2021.666515 Verlag, kostenfrei, Volltext: https://www.frontiersin.org/article/10.3389/fcell.2021.666515 
|
| Author Notes: | Annette Affolter, Anne Lammert, Johann Kern, Claudia Scherl and Nicole Rotter |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 176728151X | ||
| 003 | DE-627 | ||
| 005 | 20230426082451.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210818s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fcell.2021.666515 |2 doi | |
| 035 | |a (DE-627)176728151X | ||
| 035 | |a (DE-599)KXP176728151X | ||
| 035 | |a (OCoLC)1295679609 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Affolter, Annette |d 1977- |e VerfasserIn |0 (DE-588)124918417 |0 (DE-627)368073726 |0 (DE-576)294568190 |4 aut | |
| 245 | 1 | 0 | |a Precision medicine gains momentum |b novel 3D models and stem cell-based approaches in head and neck cancer |c Annette Affolter, Anne Lammert, Johann Kern, Claudia Scherl and Nicole Rotter |
| 264 | 1 | |c 8 July 2021 | |
| 300 | |a 27 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.08.2021 | ||
| 520 | |a Despite the current progress in the development of new concepts of precision medicine for head and neck squamous cell carcinoma (HNSCC), in particular targeted therapies and immune checkpoint inhibition (CPI), overall survival rates have not improved during the last decades. This is, on the one hand, caused by the fact that a significant number of patients presents with late stage disease at the time of diagnosis, on the other hand HNSCC frequently develop therapeutic resistance. Distinct intratumoral and intertumoral heterogeneity is one of the strongest features in HNSCC and has hindered both the identification of specific biomarkers and the establishment of targeted therapies for this disease so far. To date, there is a paucity of reliable preclinical models, particularly those that can predict responses to immune CPI, as these models require an intact tumor microenvironment (TME). The “ideal” preclinical cancer model is supposed to take both the TME as well as tumor heterogeneity into account. Although HNSCC patients are frequently studied in clinical trials, there is a lack of reliable prognostic biomarkers allowing a better stratification of individuals who might benefit from new concepts of targeted or immunotherapeutic strategies. Emerging evidence indicates that cancer stem cells (CSCs) are highly tumorigenic. Through the process of stemness, epithelial cells acquire an invasive phenotype contributing to metastasis and recurrence. Specific markers for CSC such as CD133 and CD44 expression and ALDH activity help to identify CSC in HNSCC. For the majority of patients, allocation of treatment regimens is simply based on histological diagnosis and on tumor location and disease staging (clinical risk assessments) rather than on specific or individual tumor biology. Hence there is an urgent need for tools to stratify HNSCC patients and pave the way for personalized therapeutic options. This work reviews the current literature on novel approaches in implementing three-dimensional (3D) HNSCC in vitro and in vivo tumor models in the clinical daily routine. Stem-cell based assays will be particularly discussed. Those models are highly anticipated to serve as a preclinical prediction platform for the evaluation of stable biomarkers and for therapeutic efficacy testing. | ||
| 700 | 1 | |a Lammert, Anne |d 1983- |e VerfasserIn |0 (DE-588)137533365 |0 (DE-627)695845284 |0 (DE-576)303406097 |4 aut | |
| 700 | 1 | |a Kern, Johann |d 1974- |e VerfasserIn |0 (DE-588)122749632X |0 (DE-627)1748494171 |4 aut | |
| 700 | 1 | |a Scherl, Claudia |d 1977- |e VerfasserIn |0 (DE-588)132069555 |0 (DE-627)517465426 |0 (DE-576)298927101 |4 aut | |
| 700 | 1 | |a Rotter, Nicole |d 1970- |e VerfasserIn |0 (DE-588)118085638 |0 (DE-627)079235514 |0 (DE-576)178653888 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in cell and developmental biology |d Lausanne : Frontiers Media, 2013 |g 9(2021) vom: 8$7m., Artikel-ID 666515, Seite 1-27 |h Online-Ressource |w (DE-627)770398138 |w (DE-600)2737824-X |w (DE-576)394650182 |x 2296-634X |7 nnas |a Precision medicine gains momentum novel 3D models and stem cell-based approaches in head and neck cancer |
| 773 | 1 | 8 | |g volume:9 |g year:2021 |g day:8$7m |g elocationid:666515 |g pages:1-27 |g extent:27 |a Precision medicine gains momentum novel 3D models and stem cell-based approaches in head and neck cancer |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fcell.2021.666515 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.frontiersin.org/article/10.3389/fcell.2021.666515 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210913 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 118085638 |a Rotter, Nicole |m 118085638:Rotter, Nicole |d 60000 |d 62100 |e 60000PR118085638 |e 62100PR118085638 |k 0/60000/ |k 1/60000/62100/ |p 5 |y j | ||
| 998 | |g 132069555 |a Scherl, Claudia |m 132069555:Scherl, Claudia |d 60000 |d 62100 |e 60000PS132069555 |e 62100PS132069555 |k 0/60000/ |k 1/60000/62100/ |p 4 | ||
| 998 | |g 122749632X |a Kern, Johann |m 122749632X:Kern, Johann |d 60000 |d 62100 |e 60000PK122749632X |e 62100PK122749632X |k 0/60000/ |k 1/60000/62100/ |p 3 | ||
| 998 | |g 137533365 |a Lammert, Anne |m 137533365:Lammert, Anne |d 60000 |d 62100 |e 60000PL137533365 |e 62100PL137533365 |k 0/60000/ |k 1/60000/62100/ |p 2 | ||
| 998 | |g 124918417 |a Affolter, Annette |m 124918417:Affolter, Annette |d 60000 |d 62100 |e 60000PA124918417 |e 62100PA124918417 |k 0/60000/ |k 1/60000/62100/ |p 1 |x j | ||
| 999 | |a KXP-PPN176728151X |e 3977322346 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 18.08.2021"],"id":{"eki":["176728151X"],"doi":["10.3389/fcell.2021.666515"]},"relHost":[{"disp":"Precision medicine gains momentum novel 3D models and stem cell-based approaches in head and neck cancerFrontiers in cell and developmental biology","type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 04.06.20"],"id":{"issn":["2296-634X"],"zdb":["2737824-X"],"eki":["770398138"]},"recId":"770398138","origin":[{"dateIssuedKey":"2013","publisherPlace":"Lausanne","publisher":"Frontiers Media","dateIssuedDisp":"2013-"}],"title":[{"title":"Frontiers in cell and developmental biology","title_sort":"Frontiers in cell and developmental biology"}],"titleAlt":[{"title":"FCELL"}],"pubHistory":["2013 -"],"part":{"pages":"1-27","text":"9(2021) vom: 8$7m., Artikel-ID 666515, Seite 1-27","extent":"27","year":"2021","volume":"9"},"language":["eng"]}],"recId":"176728151X","language":["eng"],"name":{"displayForm":["Annette Affolter, Anne Lammert, Johann Kern, Claudia Scherl and Nicole Rotter"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"8 July 2021"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Affolter, Annette","family":"Affolter","role":"aut","given":"Annette","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Anne","display":"Lammert, Anne","family":"Lammert"},{"display":"Kern, Johann","family":"Kern","given":"Johann","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Claudia","family":"Scherl","display":"Scherl, Claudia"},{"display":"Rotter, Nicole","family":"Rotter","role":"aut","given":"Nicole","roleDisplay":"VerfasserIn"}],"title":[{"subtitle":"novel 3D models and stem cell-based approaches in head and neck cancer","title":"Precision medicine gains momentum","title_sort":"Precision medicine gains momentum"}],"physDesc":[{"extent":"27 S."}]} | ||
| SRT | |a AFFOLTERANPRECISIONM8202 | ||